Related Experiment Video
Updated: Dec 24, 2025

Large-Scale SARS-CoV-2 Testing Utilizing Saliva and Transposition Sample Pooling
Published on: June 23, 2022
Saliva is a reliable tool to detect SARS-CoV-2
Lorenzo Azzi1, Giulio Carcano2, Francesco Gianfagna3
1Unit of Oral Medicine and Pathology, ASST dei Sette Laghi, Department of Medicine and Surgery, University of Insubria, Varese, Italy.
Saliva testing effectively detects SARS-CoV-2 in COVID-19 patients. Saliva analysis may also indicate disease progression, offering insights beyond simple viral detection.
Area of Science:
- Infectious Diseases
- Virology
- Diagnostic Medicine
Background:
- The COVID-19 pandemic necessitates reliable diagnostic tools.
- Understanding SARS-CoV-2 viral load and its clinical correlation is crucial.
Purpose of the Study:
- To analyze salivary samples from COVID-19 patients.
- To compare salivary results with clinical and laboratory data.
- To assess saliva's utility in diagnosing and monitoring COVID-19.
Main Methods:
- Real-time reverse transcription polymerase chain reaction (rRT-PCR) analysis of salivary samples from 25 COVID-19 patients.
- Collection of clinical data including age, sex, comorbidities, and medications.
- Registration of lactate dehydrogenase (LDH) and ultrasensitive C-reactive protein (usCRP) levels concurrently with salivary swab collection.
Main Results:
- All 25 tested salivary samples were positive for SARS-CoV-2.
- An inverse association was observed between LDH levels and cycle threshold (Ct) values, suggesting a correlation with viral load.
- Two patients demonstrated positive salivary results on days when respiratory swabs indicated viral clearance.
Conclusions:
- Saliva is a dependable medium for SARS-CoV-2 detection.
- Saliva's role in COVID-19 diagnostics extends to qualitative detection and potentially monitoring clinical disease evolution.
More Related Videos
11:11Efficient SARS-CoV-2 Quantitative Reverse Transcriptase PCR Saliva Diagnostic Strategy utilizing Open-Source Pipetting Robots
Published on: February 11, 2022
10:25Detection of SARS-CoV-2 Neutralizing Antibodies using High-Throughput Fluorescent Imaging of Pseudovirus Infection
Published on: June 5, 2021